Skip to content

STEPWISE Parkinson: A smartphone based, titrated exercise solution for patients with Parkinson*s disease in daily life - pilot study

STEPWISE Parkinson: A smartphone based, titrated exercise solution for patients with Parkinson*s disease in daily life - pilot study - STEPWISE Parkinson - pilot study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49229
Enrollment
30
Registered
2020-09-08
Start date
2020-11-09
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bewegingsstoornis, ziekte van Parkinson Parkinson's disease

Interventions

Patients will be randomized into one of three groups. All groups will be encouraged to increase their physical activity level, measured in step counts on the patients* own smartphone with a differen

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) idiopathic PD 2) Hoehn and Yahr 1-3 3) able to understand the Dutch language 4) able to walk independently 5) less than 30 minutes of outdoor and/or sports activities per day (LASA Physical Activity Questionnaire (LAPAQ)) 6) takes less than 7.000 steps/day during 1-week baseline

Exclusion criteria

Exclusion criteria: 1) weekly falls in the previous 3 months 3) medical conditions that hamper mobility 4) living in a nursing home 5) cognitive impairments that hamper use of the motivational app on the smartphone (Montreal Cognitive Assessment

Design outcomes

Primary

MeasureTime frame
The main study parameter will be change in number of steps from baseline to follow-up (after four weeks), measured with the patients* own smartphone

Secondary

MeasureTime frame
Secondary outcomes will be usability and enjoyment of the application and different measures of physical fitness, motor- and non-motor functioning.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)